ArticleNPJ vaccines2023

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.

David Benkeser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.